Trial Profile
Phase 2 study of carboplatin and weekly nab-paclitaxel for elderly squamous cell lung cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Oct 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 19 Oct 2019 Status changed from recruiting to discontinued.
- 15 Oct 2013 New trial record